The Grand At Bethany Skilled Nursing And Therapy | |
7000 Northwest 32nd Street, Bethany, Oklahoma 73008 | |
(405) 789-7242 | |
Name | The Grand At Bethany Skilled Nursing And Therapy |
---|---|
Location | 7000 Northwest 32nd Street, Bethany, Oklahoma |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 161 |
Occupancy Rate | 54.97% |
Medicare ID (CCN) | 375107 |
Legal Business Name | Putnam City Convalescent Center, Llc |
Ownership Type | For Profit - Partnership |
NPI Number | 1801991534 |
Organization Name | PUTNAM CITY CONVALESCENT CENTER, LLC |
Doing Business As | GRACE LIVING CENTER - BETHANY |
Address | 7000 Nw 32nd St, Bethany, OK 73008 |
Phone Number | 405-789-7242 |
News Archive
The Florida Society of Pain Management Providers moves to set the record straight on the issue of patient privacy and the Prescription Drug Monitoring Program.
Motivating willingness to change is important in treating a person with severe worry. For this, integrating motivational interviewing (MI) techniques into the commonly practised cognitive behavioral therapy (CBT) is the ideal option, a study led by a York University researcher reveals.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Florida Society of Pain Management Providers moves to set the record straight on the issue of patient privacy and the Prescription Drug Monitoring Program.
Motivating willingness to change is important in treating a person with severe worry. For this, integrating motivational interviewing (MI) techniques into the commonly practised cognitive behavioral therapy (CBT) is the ideal option, a study led by a York University researcher reveals.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $58257 |
Number of Payment Denials | 1 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 5.38 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.42 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.63 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.63 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.99 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.98 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.51 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 91.27 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.28 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.02 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.5 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 12.9 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.08 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 14.47 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 75.98 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.63 | 82.93 |
News Archive
The Florida Society of Pain Management Providers moves to set the record straight on the issue of patient privacy and the Prescription Drug Monitoring Program.
Motivating willingness to change is important in treating a person with severe worry. For this, integrating motivational interviewing (MI) techniques into the commonly practised cognitive behavioral therapy (CBT) is the ideal option, a study led by a York University researcher reveals.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health. One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
› Verified 2 days ago
The Grand At Bethany Skilled Nursing And Therapy Location: 7000 Northwest 32nd Street, Bethany, Oklahoma 73008 Phone: (405) 789-7242 | |